000 | 01335 a2200409 4500 | ||
---|---|---|---|
005 | 20250513150622.0 | ||
264 | 0 | _c19980915 | |
008 | 199809s 0 0 fre d | ||
022 | _a0035-3639 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAbramowicz, D | |
245 | 0 | 0 |
_a[Mycophenolate mofetil]. _h[electronic resource] |
260 |
_bRevue medicale de Bruxelles _cJun 1998 |
||
300 |
_a139-43 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAcute Disease |
650 | 0 | 4 |
_aAdrenal Cortex Hormones _xadverse effects |
650 | 0 | 4 |
_aB-Lymphocytes _xdrug effects |
650 | 0 | 4 |
_aCell Division _xdrug effects |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 |
_aCyclosporine _xadverse effects |
650 | 0 | 4 |
_aDiarrhea _xchemically induced |
650 | 0 | 4 |
_aGraft Rejection _xprevention & control |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunosuppressive Agents _xadverse effects |
650 | 0 | 4 | _aIncidence |
650 | 0 | 4 |
_aKidney _xdrug effects |
650 | 0 | 4 |
_aKidney Transplantation _ximmunology |
650 | 0 | 4 |
_aLeukopenia _xchemically induced |
650 | 0 | 4 |
_aMycophenolic Acid _xadverse effects |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aT-Lymphocytes _xdrug effects |
700 | 1 | _aBroeders, N | |
700 | 1 | _aWissing, M | |
700 | 1 | _aSternon, J | |
773 | 0 |
_tRevue medicale de Bruxelles _gvol. 19 _gno. 3 _gp. 139-43 |
|
999 |
_c9663030 _d9663030 |